Publications for Cattepoel, S
|Up a level|
Hanenberg, Michael; McAfoose, Jordan; Kulic, Luka; Welt, Tobias; Wirth, Fabian; Parizek, Petra; Strobel, Lisa; Cattepoel, Susann; Späni, Claudia; Derungs, Rebecca; Maier, Marcel; Plückthun, Andreas; Nitsch, Roger M (2014). Amyloid-β peptide-specific DARPins as a novel class of potential therapeutics for Alzheimer disease. Journal of Biological Chemistry, 289(39):27080-27089.
Cattepoel, S; Hanenberg, M; Kulic, L; Nitsch, R M (2011). Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease. PLoS ONE, 6(4):e18296.
Kulic, L; Wollmer, M A; Rhein, V; Pagani, L; Kuehnle, K; Cattepoel, S; Tracy, J; Eckert, A; Nitsch, R M (2011). Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration. Neurobiology of Aging, 32(10):1827-1838.
Cattepoel, S. Antibodies and single-chain variable fragments as therapeutic tools in transgenic mouse models of Alzheimer's disease. 2009, University of Zurich, Faculty of Science.